Title

Can Surgeons Improve Survival in Stage IV Melanoma?

Publication/Presentation Date

4-1-2008

Abstract

Successful systemic management of stage IV melanoma continues to be elusive because of the paucity of effective therapies. This has fueled the continued interest in surgical resection. Several single-institution studies and a current, large, multi-institutional phase III trial have demonstrated a survival benefit for patients who underwent surgical resection for melanoma metastases. Incorporating these results into new approaches using multimodality treatment may enhance survival in patients with stage IV melanoma.

Volume

97

Issue

5

First Page

462

Last Page

468

ISSN

0022-4790

Disciplines

Hematology | Medical Sciences | Medicine and Health Sciences | Oncology

PubMedID

18270974

Peer Reviewed for front end display

Peer-Reviewed

Department(s)

Department of Medicine, Hematology-Medical Oncology Division, Department of Medicine Faculty

Document Type

Article